Graduated from:
- The University of Edinburgh (UK)
Location History:
- St. Lucia., AU (1999)
- Buranda, AU (2005)
- St Lucia, AU (2010)
- Brisbane, AU (2003 - 2011)
- Queensland, AU (2011)
- S. Lucia, AU (2014 - 2018)
- St. Lucia, AU (1999 - 2020)
Company Filing History:
14 out of 340 
5 out of 122 
3 out of 3 Years Active: 1999-2020
Title: Ian Hector Frazer: A Pioneer in HPV Vaccine Development
Introduction
Ian Hector Frazer, a prominent figure in the field of immunology, is based in S. Lucia, Australia. With a remarkable portfolio of 24 patents, his contributions have significantly advanced the understanding and treatment of human papillomavirus (HPV) and other related conditions.
Latest Patents
Frazer's latest patents showcase his innovative approach to immunotherapy. One of his prominent inventions is an immunomodulating composition for treatment that involves therapeutic compositions inducing an immune response to HPV. This patent reveals methods for introducing and expressing a nucleic acid molecule encoding an immunogenic HPV antigen in a subject, aiming to generate a robust immune response.
Another noteworthy patent details the use of a first antigen alongside a second modified antigen that enhances intracellular proteolytic degradation. This invention aims to induce both humoral and cellular immunity, allowing for a dual approach to combatting conditions with long latency periods. Such innovations enhance the capability of immunogenic compositions, combining prophylaxis and therapy in a single delivery.
Career Highlights
Ian Hector Frazer has made significant strides in his career, primarily during his tenure at the University of Queensland, where his research has paved the way for novel vaccine strategies and therapies. His innovative work has attracted attention from various sectors, further solidifying his position as a leading inventor in immunology.
Collaborations
Throughout his career, Frazer has collaborated with several notable individuals, including Jian Zhou and Stirling John Edwards. These partnerships have fostered a dynamic exchange of ideas and research that has contributed to his success and the advancement of immunological studies.
Conclusion
Ian Hector Frazer stands out as a visionary inventor, whose 24 patents reflect his dedication to advancing the fields of immunology and vaccine development. His latest innovations not only enhance our understanding of HPV but also provide new avenues for prevention and treatment, making significant contributions to global health.